Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
Sven E. Eriksson, Ping Zheng, Scott Morton, Nicole Maurer, Toshitaka Hoppo, Blair A. Jobe and Shahin Ayazi
Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Life Sciences & Biomedicine Science & Technology Surgery
Introduction Pyloroplasty and gastric peroral endoscopic myotomy (G-POEM) are effective surgeries for gastroparesis. The primary aim of this study was to evaluate outcomes of pyloroplasty and G-POEM in patients with gastroparesis and determine factors associated with favorable outcome. The secondary aim was to assess the utility of clinical response to preoperative pyloric dilation or botulinum toxin injection (Botox) on surgical outcome, a factor conventionally used as a favorable marker.Methods There were 204 patients who underwent pyloroplasty (n = 177) or G-POEM (n = 27) for gastroparesis at our institution from 2014 to 2021. Demographic and clinical parameters were analyzed to assess their impact on surgical outcome. A subgroup of patients who had pyloric dilation or Botox injection were assessed separately. Favorable outcome was defined as patient reported complete resolution of the predominant gastroparesis symptom.Results Favorable outcome was achieved in 78.4% of patients (pyloroplasty: 79.7% and G-POEM: 70.4%, p = 0.274). Among 61 patients where pre- and postoperative gastric emptying studies (GES) were available, mean 4-hour retention significantly improved from 33.5 to 15.0% (p < 0.001) and 77.0% of patients achieved normalization.Favorable outcome was not significantly impacted by etiology of gastroparesis (p = 0.120), GERD (p = 0.518), or primary gastroparesis symptom (p = 0.244). Age >= 40 was a significant predictor of favorable surgical outcome on multivariate analysis [OR: 2.476 (1.224-5.008), p = 0.012]. Among the patients who had preoperative dilation (n = 82) or Botox injection (n = 46), response to these interventions was not a predictor of favorable surgical outcome (p = 0.192 and 0.979, respectively). However, preoperative Botox injection, regardless of response to injection, was associated with favorable surgical outcome [OR: 3.205 (CI 1.105-9.299), p = 0.032].Conclusion Symptomatic improvement after pyloroplasty or G-POEM is independent of etiology of gastroparesis, GERD, and primary symptom. Response to dilation or Botox are not markers of response to surgery. However, patients who receive Botox are 3.2 times more likely to improve postoperatively.
Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
Creators
Sven E. Eriksson - Allegheny Health Network
Ping Zheng - Allegheny Health Network
Scott Morton - Allegheny Health Network
Nicole Maurer - Allegheny Health Network
Toshitaka Hoppo - Allegheny Health Network
Blair A. Jobe - Drexel University
Shahin Ayazi - Allegheny Hlth Network, Esophageal Inst, 4815 Liberty Ave,Suite 439, Pittsburgh, PA 15224 USA
Publication Details
Surgical endoscopy, v 37(6), pp 4360-4369
Publisher
Springer Nature
Number of pages
10
Resource Type
Journal article
Language
English
Academic Unit
Surgery
Web of Science ID
WOS:000930460900001
Scopus ID
2-s2.0-85147581139
Other Identifier
991021860732104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
Web of Science research areas
Surgery
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services